BEUDAMED
    13 results · 29ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    Parky App

    FDA 510(k)
    FDA Class 2 ·Neurology

    Gold Anchor

    FDA UDI
    Naslund Medical AB·07340145700827·22G (0.7mm) 8 cm needle with 0.40x20 mm marker

    GIRAFFE BLUE SPOT PT LITE

    FDA 510(k)
    FDA Class 2 ·General Hospital

    MICROSCAN MICROSTEP PLUS PANEL NEW ANTIMICROBIAL - CEFUROXIME

    FDA 510(k)
    FDA Class 2 ·Microbiology

    MEDLINE

    FDA Adverse Event
    Malfunction ·MEDLINE INDUSTRIES, INC.·Product code FMF·March 10, 2023

    ACCESS

    FDA Adverse Event
    Malfunction ·BAXTER HEALTHCARE·Product code FPA·August 23, 2011

    AQUARIUS (REGULAR)

    FDA Adverse Event
    Malfunction ·EDWARD LIFESCIENCES·Product code FII·October 31, 2008

    OT PING METER

    FDA Adverse Event
    Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·July 11, 2013

    LINEAR? 3-6

    FDA Adverse Event
    Injury ·BOSTON SCIENTIFIC NEUROMODULATION CORPORATION·Product code LGW·May 27, 2025

    M2A-MAGNUM MOD HD SZ 54MM

    FDA Adverse Event
    Injury ·ZIMMER BIOMET, INC.·Product code LPH·July 30, 2019

    Torcon NB Advantage Catheters - Product Usage: Intended for use in the peripheral and coronary vascular system, including the carotid arteries, in giographic procedures by physicians trained and experienced in angiographic techniques.

    FDA Enforcement
    Class II ·Terminated·Cook Inc.·November 27, 2019

    Torcon NB Advantage Catheters - Product Usage: Intended for use in the peripheral and coronary vascular system, including the carotid arteries, in giographic procedures by physicians trained and experienced in angiographic techniques.

    FDA Enforcement
    Class II ·Terminated·Cook Inc.·November 27, 2019

    ExacTrac 5.5, an Image Processing System used for patient positioning for radiation therapy or radiosurgery.

    FDA Enforcement
    Class II ·Terminated·Brainlab AG·June 11, 2014